Cargando…
Safety and efficacy of directly‐acting antiviral therapy for chronic hepatitis C virus in elderly people
INTRODUCTION: In Italy, the prevalence of hepatitis C virus (HCV) infection is higher in the elderly, although the efficacy and safety of treatment in this population has not been extensively studied. Moreover, little is known about how much pharmacological interaction affects eligibility to treatme...
Autores principales: | De Santis, Adriano, Maggi, Daniela, Lubrano Lobianco, Federica |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8711222/ https://www.ncbi.nlm.nih.gov/pubmed/34964012 http://dx.doi.org/10.1002/agm2.12190 |
Ejemplares similares
-
Clinical efficacy and tolerability of direct-acting antivirals in elderly patients with chronic hepatitis C
por: Sherigar, Jagannath M., et al.
Publicado: (2017) -
The efficacy and safety of direct-acting antiviral drugs in the management of hepatitis C virus-related arthritis
por: Alian, Samah M., et al.
Publicado: (2020) -
Efficacy and Safety of Direct Acting Antivirals in Kidney Transplant Recipients with Chronic Hepatitis C Virus Infection
por: Lin, Ming V., et al.
Publicado: (2016) -
Assessing the Safety of Direct-Acting Antiviral Agents for Hepatitis C
por: McGlynn, Elizabeth A., et al.
Publicado: (2019) -
Hepatitis C Virus in the Elderly in the Direct-Acting Antiviral Era: from Diagnosis to Cure
por: Mohammed Abdul, Mubeen Khan, et al.
Publicado: (2020)